U.S. IPO market posts record fundraising as deal flow stays below past peaks

U.S. IPO market posts record fundraising as deal flow stays below past peaks
IPO market breaks records

After several subdued years, the U.S. initial public offering market in 2026 is producing record fundraising totals without a return to historically high listing volumes. The gap is being driven by a handful of oversized deals, leaving much of the market still constrained by weaker sentiment, higher yields and uneven investor demand.

Highlights

  • Anthropic raised $81.3 billion in its IPO, surpassing SpaceX's $75 billion to set a global record, with both totals potentially rising further.
  • Two deals—Anthropic and SpaceX—make up about two-thirds of 2026's IPO proceeds, despite deal activity only showing gradual improvement since 2022.
  • IPO market activity is concentrated in technology, aerospace, and biotech, with an index of IPO stocks underperforming the S&P 500 and smaller issuers delaying listings.

Record proceeds driven by mega listings

As reported by Reuters, this year's fundraising surge is being propelled largely by a small number of very large offerings rather than a broad revival in new listings. Anthropic's debut on Thursday is set to cap a year in which the AI company raised $81.3 billion in its IPO, overtaking SpaceX's $75 billion deal to become the world's largest IPO, with both totals still able to rise if underwriters exercise additional share purchase options.

Matt Kennedy, senior IPO market strategist at Renaissance Capital, said 2026 is the year of the mega IPO, adding that proceeds figures alone make the market look bigger than it is. He said underlying deal activity suggests only a gradual improvement since 2022, rather than a full-scale rebound.

Selective recovery leaves smaller issuers waiting

Behind the record totals, the market has been markedly quieter, especially in the second half of the year as the AI trade weakens, bond yields climb and expectations of interest-rate hikes weigh on investor sentiment. Lukas Muehlbauer, an associate at IPOX, said SpaceX and Anthropic alone account for about two-thirds of this year's proceeds, overstating how broad the recovery really is.

Activity remains concentrated in technology, aerospace and biotech, while many companies in other sectors still lack a viable listing window. Muehlbauer described 2026 as a selective reopening rather than a broad-based revival, with many companies that held back this year now looking to 2027.

The uneven recovery and investor focus on the largest offerings are also making it harder for smaller issuers to attract attention, prompting many to delay plans. Anthropic stands as the only major IPO in November, and an index tracking IPO stocks is underperforming the broader S&P 500 this year, underscoring continued selectivity in demand for newly listed companies.

Previously, we outlined the main factors behind Anthropic IPO record as investor demand surged for advanced AI model developers.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.